Amelubant
- Generic Name
- Amelubant
- Drug Type
- Small Molecule
- Chemical Formula
- C33H34N2O5
- CAS Number
- 346735-24-8
- Unique Ingredient Identifier
- E0018IF0K4
- Indication
Investigated for use/treatment in asthma, chronic obstructive pulmonary disease (COPD), cystic fibrosis, and rheumatoid arthritis.
Effect of BIIL 284 BS on the Pharmacokinetics of Theophylline in Healthy Male Volunteers
- First Posted Date
- 2014-10-24
- Last Posted Date
- 2014-10-24
- Lead Sponsor
- Boehringer Ingelheim
- Target Recruit Count
- 16
- Registration Number
- NCT02273440
Effect of Different Food Compositions on Bioavailability of BIIL 284 BS in Healthy Male Volunteers
Phase 1
Completed
- Conditions
- Healthy
- Interventions
- First Posted Date
- 2014-10-24
- Last Posted Date
- 2014-10-24
- Lead Sponsor
- Boehringer Ingelheim
- Target Recruit Count
- 24
- Registration Number
- NCT02273427
Study to Evaluate the Effect of Multiple Doses of BIIL 284 BS on the Pharmacokinetics of Prednisone in Healthy Male Subjects
- First Posted Date
- 2014-10-20
- Last Posted Date
- 2014-10-20
- Lead Sponsor
- Boehringer Ingelheim
- Target Recruit Count
- 20
- Registration Number
- NCT02268149
Pharmacokinetics, Safety and Tolerability of BIIL 284 BS in Patients With Hepatic Impairment in Comparison to Healthy Volunteers
- First Posted Date
- 2014-10-16
- Last Posted Date
- 2014-10-16
- Lead Sponsor
- Boehringer Ingelheim
- Target Recruit Count
- 32
- Registration Number
- NCT02265627
Effect of BIIL 284 BS on Patients With Chronic Obstructive Pulmonary Disease (COPD)
Phase 2
Completed
- Conditions
- Pulmonary Disease, Chronic Obstructive
- Interventions
- Drug: Placebo
- First Posted Date
- 2014-09-25
- Last Posted Date
- 2014-09-26
- Lead Sponsor
- Boehringer Ingelheim
- Target Recruit Count
- 53
- Registration Number
- NCT02249338
The Effect of BIIL 284 BS on Induced-sputum Variables in Patients With Bronchial Asthma
- First Posted Date
- 2014-09-25
- Last Posted Date
- 2014-09-26
- Lead Sponsor
- Boehringer Ingelheim
- Target Recruit Count
- 38
- Registration Number
- NCT02249312
Drug Development Updates
Stay informed with timely notifications on clinical trials, regulatory changes, and research advancements related to this medication.
© Copyright 2025. All Rights Reserved by MedPath